Irvine, CA - A court injunction preventing the sale of Medtronic's CoreValve in Germany went into effect yesterday, the manufacturer of the CoreValve's chief competitor, Edwards Lifesciences, ...
Edwards Lifesciences and Medtronic have been battling each other for half a dozen years (at least) over a heart valve patent, and recent news suggests Germany's District Court of Mannheim will favor ...
The FDA today approved Medtronic's CoreValve transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis who are unable to undergo conventional open-heart surgery.
DUBLIN and CHICAGO - April 3, 2016 - Medtronic plc (MDT) today announced new data from the High Risk Study of the CoreValve U.S. Pivotal Trial that show superior clinical outcomes for transcatheter ...
Medtronic's CoreValve system today gained a second indication from the FDA for use in patients with severe aortic stenosis who are at high risk for surgery. The transcatheter aortic valve replacement ...
Leading medical device major Medtronic Inc.'s (MDT) self-expanding CoreValve transcatheter aortic valve system recently exhibited cost efficiency in transcatheter aortic valve replacement (:TAVR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results